Meta Platforms shares dipped 1.2% in pre‑market trading on Thursday, after the firm disclosed the $95bn capital‑raising scheme.
The primary portion will issue about $35bn of common and preferred shares, while the at‑the‑market program will allow Meta to sell up to $60bn in Class C non‑voting shares over time, providing a flexible source of liquidity.
This combined equity push ranks among the largest in the tech sector, and the ATM structure signals a shift from Meta’s prior reliance on debt and share buybacks to a more market‑driven approach.
According to the filing, the proceeds are earmarked chiefly for AI development, with the expectation that the infusion will accelerate product launches and help the company compete in the rapidly evolving AI landscape.
Analysts note that while the new shares will dilute earnings per share in the short term, the long‑term benefits of accelerated AI initiatives could offset the dilution, keeping investors focused on future growth.